Pharm-AD SRL
Pharm-AD reported total assets of 659,306 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Pharm-AD shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets +67 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharm-AD's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 150,580 € | ||||
| Equity | 476,654 € | ||||
| Cash | 344,323 € | ||||
| EBITDA | 220,594 € | ||||
| Total assets | 659,306 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 30 Jan 2025
- Year ended 30 Jun 2023filed on 24 Jan 2024
- Year ended 30 Jun 2022filed on 30 Dec 2022
- Year ended 30 Jun 2021filed on 24 Jan 2022
Pharm-AD's financial analysis
- Solvency72.3%sector median: 47.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharm-AD
Pharm-AD's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0819.236.165
- VAT number
- BE0819236165
- Peppol
- Registered · 0208:0819236165 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Oct 2009
- Registered office
- 1370 Jodoigne
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Pharm-AD (SRL) has been based in Jodoigne since 2009, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 150,580 € and equity of 476,654 €; its revenue is not published. Its solvency stands at 72.3%, above the median of its sector (47.1%).
Companies similar to Pharm-AD
Companies in the same business, of comparable size and area, outside its group.
- Cvyds Other business support service activities n.e.c. Chaumont-Gistoux · balance sheet 658,995 €
- DBS Agro Other business support service activities n.e.c. Sint-Katelijne-Waver · balance sheet 656,388 €
- KV consulting Other business support service activities n.e.c. Halen · balance sheet 653,691 €
- Vatraco Other business support service activities n.e.c. Heusden-Zolder · balance sheet 653,614 €
- Jachribel Other business support service activities n.e.c. Roeselare · balance sheet 653,561 €
- Moerman Nico Other business support service activities n.e.c. Kruisem · balance sheet 652,528 €
- Sevico Other business support service activities n.e.c. Alken · balance sheet 651,904 €
- Tokapi - Invest Other business support service activities n.e.c. Sint-Niklaas · balance sheet 646,398 €
Frequently asked questions about Pharm-AD
What is the revenue of Pharm-AD?
Pharm-AD files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharm-AD?
In Belgium, the VAT number is the company number prefixed with BE: BE0819236165 for Pharm-AD, if the company is VAT-registered. Its company number (CBE) is 0819.236.165.
Where is the registered office of Pharm-AD?
According to the CBE register, the registered office of Pharm-AD is in 1370 Jodoigne.
What is the equity of Pharm-AD?
At the close of the 2025 financial year, the equity of Pharm-AD amounts to 476,654 €, a solvency of 72.3% of total assets.
Who manages Pharm-AD?
The register lists 2 active mandates at Pharm-AD. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharm-AD
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →